Disruption of Th1/Th2 cytokine balance by cocaine is mediated by corticosterone

Immunopharmacology

Volumn 37, Issue 1, 1997, Pages 25-33

  Stanulis, Eric D ^a   Jordan, Stephen D ^a   Rosecrans, John A ^a   Holsapple, Michael P ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DOW CHEMICAL COMPANY   (United States)

Author keywords

Cocaine; Corticosterone; Cytokine; Immunoenhancement; Immunomodulation; Th1 Th2

Indexed keywords

COCAINE; CORTICOSTERONE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG MECHANISM; FEMALE; HELPER CELL; HUMORAL IMMUNITY; IMMUNOMODULATION; IMMUNOTOXICITY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHEEP ERYTHROCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODY FORMATION; COCAINE; CORTICOSTERONE; CYTOKINES; FEMALE; HYPERSENSITIVITY, DELAYED; MICE; MICE, INBRED STRAINS; NARCOTICS; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 0030837914     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(96)00167-1     Document Type: Article

References (20)

1. Byron KA, Varigos G, Wootton A. Hydrocortisone inhibition of human interleukin-4. Immunology 1992; 77: 624-626.
2. Clerici M, Shearer GM. A Th1-Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 1993; 14: 107-111.
3. Clerici M, Bevilacqua M, Vago T, Villa ML, Shearer GM, Norbiato G. An immunoendocrinological hypothesis of HIV infection. The Lancet 1994; 343: 1552-1553.
4. Daynes RA, Araneo BA. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 1989; 19: 2319-2325.
5. Di Francesco P, Marini S, Pica F, Favalli C, Tubaro E, Garaci E. In vivo cocaine administration influences lymphokine production and humoral immune response. Immunol. Res. 1992; 11: 74-77.
6. Holsapple MP. The plaque-forming cell (PFC) response in immunotoxicology: An approach to monitoring the primary effector function of B lymphocytes. In: G Burleson, JH Dean, AE Munson Eds. Methods of Immunotoxicology, Vol. 1. New York: Wiley-Liss, 1995; 71-108.
7. Holsapple MP, Munson AE. Immunotoxicology of abused drugs. In: JH Dean, MI Luster, AE Munson, H Amos Eds. Immunotoxicology and Immunopharmacology. New York: Raven Press, 1985; 381-392.
8. Holsapple MP, Munson AE, Munson JA, Bick, PH. Suppression of cell-mediated immunocompetence after subchronic exposure to diethylstilbestrol in female B6C3F1 mice. J. Pharmacol. Exp. Ther. 1983; 227: 130-138.
9. Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol. 1989a; 7: 145-173.
10. Mosmann TR, Coffman RL. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 1989b; 46: 111-147.
11. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T-cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986; 136: 2348-2357.
12. Mosmann TR, Schumacher JH, Street NF, Budd R, O'Garra A, Fong TAT, Bond MW, Moore KWM, Sher A, Fiorentino DF. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol. Rev. 1991; 123: 209-229.
13. Powrie F, Coffman RL. Cytokine regulation of T-cell function: Potential for therapeutic intervention. Trends Pharmacol. Sci. 1993; 14: 164-168.
14. Pruett SB, Ensley DK, Crittenden PL. The role of chemical-induced stress responses in immunosuppression: A review of quantitative associations and cause-effect relationships between chemical-induced stress responses and immunosuppression. J. Toxicol. Environ. Health 1993; 39: 163-192.
15. Rook GAW, Onyebujoh P, Stanford JL. TH1/TH2 switching and loss of CD4+ T cells in chronic infections: An immunoendocrinological hypothesis not exclusive to HIV. Immunol. Today 1993; 14: 568-569.
16. Shearer GM, Clerici M. T-helper cell immune dysfunction in asymptomatic, HIV-1 seropositive individuals: The role of Th1-Th2 cross-regulation. In: RL Coffman Ed. Chemical Immunology, Vol. 54: Regulation and Functional Significance of T-Cell Subsets. New York: Karger, 1992; 21-43.
17. Snijdewint FGM, Kapsenberg ML, Wauben-Penris PJJ, Bos JD. Corticosteroids class-dependently inhibit in vitro Th1- and Th2-type cytokine production. Immunopharmacology 1995; 29: 93-101.
18. Stanulis ED, Matulka RA, Jordan SD, Rosecrans JA, Holsapple MP. Role of corticosterone in the enhancement of the antibody response after acute cocaine administration. J. Pharmacol. Exp. Ther. 1997; 280: 284-291.
19. Wang Y, Huang DS, Watson RR. In vivo and in vitro cocaine modulation on production of cytokines in C57BL/6 mice. Life Sci. 1994; 54: 401-411.
20. Wu CY, Fargeas C, Nakajima T, Delespesse G. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur. J. Immunol. 1991; 21: 2645-2647.